Key factors in the rising cost of new drug discovery and development
- 1 May 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 3 (5), 417-429
- https://doi.org/10.1038/nrd1382
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Patents, Innovation and Access to New PharmaceuticalsJournal of International Economic Law, 2002
- The Value of Improving the Productivity of the Drug Development ProcessPharmacoEconomics, 2002
- Effective patent life in pharmaceuticalsInternational Journal of Technology Management, 2000
- Health Care For The Elderly: How Much? Who Will Pay For It?Health Affairs, 1999
- Longer Patents for Increased Generic Competition in the USPharmacoEconomics, 1996
- Success rates for new drugs entering clinical testing in the United StatesCancer Cell, 1995
- Trends in Drug Development Costs, Times, and RisksDrug Information Journal, 1995
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- A closer look at the returns and risks of pharmaceutical R&DJournal of Health Economics, 1986